Understanding and Treating Substance Use Disorder and Comorbid Conditions in Veterans' Real-Life Settings
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Aug 29, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and treating substance use disorder (SUD) among Veterans. The researchers aim to help patients identify what triggers their substance use and how to manage those triggers better. They will create personalized models for each participant that link their substance use, urges, and other related symptoms, such as anxiety, depression, or PTSD. By analyzing these models together, the study hopes to find common causes of substance use and recovery in Veterans. Participants will also receive feedback on their personal models to see if this helps improve their substance use and related symptoms.
To be eligible for the study, participants need to be Veterans who currently show signs of substance use disorder, as determined by specific screening tests. They should have used substances in the past month and have access to a smartphone or tablet for completing surveys. However, those who are currently in inpatient treatment or under the influence of drugs or alcohol when they sign up cannot participate. The study is not yet recruiting participants, but once it begins, those who join can expect to learn more about their triggers and receive tailored feedback that may help them in their recovery journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion criteria for this study are intended to include most Veterans with SUD
- * inclusion criteria are current probable SUD as indicated by:
- • a clinical score on the alcohol use disorders identification test (AUDIT) or drug use disorders identification test (DUDIT)
- • past-month substance use
- • a reliable access to a smartphone, tablet, or other device with capability of accessing and completing surveys throughout the day
- • this will exclude those who are currently completing inpatient treatment
- Exclusion Criteria:
- • exclusion criteria are being under the influence of a judgment-impairing substance at the time of consent (e.g., cannabis, alcohol, illicit opioids)
- • participants will be invited to return another day
- • being legally compelled to complete treatment
- • or being under civil commitment
- • due to lack of ability to give autonomous consent in these situations
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
Patients applied
Trial Officials
Brittany Stevenson, PhD
Principal Investigator
Minneapolis VA Health Care System, Minneapolis, MN
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported